Case of culture-confirmed clinically typical haemorrhagic colitis caused by verocytotoxin-producing (VT+) Escherichia coli O157 and age- and sex-matched control patients were examined for antibodies to E. coli O157. Serum samples from 28 cases and 34 patients in control group 1 were examined for VT1- and VT2-neutralising antibodies, E. coli O157 agglutinating antibodies, and by an enzyme immunoassay (EIA) technique for IgG antibodies against smooth lipopolysaccharide purified from E. coli O157 and for IgG antibodies against whole intact E. coli O157 cells. Differences between antibody tires were significant when compared by a Wilcoxon two-sample test for E. coli O157 agglutinating antibodies (p < 0.05) and IgG antibodies against whole cells (p < 0.001). The whole-cell EIA was used further to examine faecal samples from 93 cases and 47 patients in control group 2 for IgA antibodies. Elevated levels of faecal IgA specific for E. coli O157 were found in 59 (63.4%) of 93 cases but in only 10 (21.2%) of 47 control patients (p < 0.001); follow-up faecal samples from five cases all showed marked rises in levels of IgA that appeared to coincide with cessation of excretion of the organism. Detection of specific faecal IgA with a whole-cell EIA, although requiring further evaluation, may be a useful addition to tests currently available for the diagnosis of infection by VT+E. coli O157.
SmithHR,
RoweB,
GrossRJ,
FryNK,
ScotlandSM.
Haemorrhagic colitis and verocytotoxin-producing Escherichia coli in England and Wales. Lancet1987; 1:1062–1065
ChapmanPA,
WrightDJ,
NormanP.
Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source. Epidemiol Infect1989; 102:439–445
KarmaliMA,
PetrieM,
LimC,
FlemingPC,
ArbusGS,
LiorH.
The association between idiopathic hemolytic-uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis1985; 151:775–782
ScotlandSM,
RoweB,
SmithHR,
WillshawGA,
GrossRJ.
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic-uraemic syndrome and their detection by specific DNA probes. J Med Microbiol1988; 25:237–243
RatnamS,
MarchSB,
SpragueWD,
SeversD,
SullivanRM.
Are humans a source of Escherichia coli O157.H7, the agent of hemorrhagic colitis?. N Engl J Med1986; 315:1612–1613
CarterAO,
BorczykAA,
CarlsonJA et al. A severe outbreak of Escherichia coli O157.H7 associated hemorrhagic colitis in a nursing home. N Engl J Med1987; 317:1496–1500
MarchSB,
RatnamS.
Sorbitol-MacConkey medium for the detection of Escherichia coli O157.H7 associated with hemorrhagic colitis. J Clin Microbiol1986; 23:869–872
WillshawGA,
SmithHR,
ScotlandSM,
RoweB.
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol1985; 131:3047–3053
JacksonMP,
NeillRJ,
O’BrienAD,
HolmesRK,
NewlandJW.
Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett1987; 44:109–114
JacksonMP.
Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11- dUTP. J Clin Microbiol1991; 29:1910–1914
TarrPI,
NeillMA,
ClausenCR,
WatkinsSL,
ChristieDL,
HickmanRO.
Escherichia coli O157: H7 and the hemolytic- uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis1990; 162:553–556
NotenboomRH,
BorczykA,
KarmaliMA,
DuncanLM.
Clinical relevance of a serological cross-reaction between Escherichia coli 0151 and Brucella abortus. Lancet1987; 2:745
BitzanM,
MoebiusE,
LudwigK,
Muller-WiefelDE,
Heese-mannJ,
KarchH.
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. JPediatr1991; 119:380–385
WestphalO,
JannK.
Bacterial lipopolysaccharides - extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry1965; 5:83–91
KarkhanisYD,
ZeltnerJY,
JacksonJJ,
CarloDJ.
A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem1978; 85:595–601
ZadikP.
An enzyme-linked immunosorbent assay to detect IgG antibodies to cell surface components of Pseudomonas cepacia in patients with cystic fibrosis. Serodiagn Immun- other Infect Dis1988; 2:349–356
ChapmanPA,
RushBA,
McLauchlinJ.
An enzyme immuno assay for detecting Cryptosporidium in faecal and environmental samples. J Med Microbiol1990; 32:233–238
AleksicS,
KarchH,
BockemuhlJ.
A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria. ZblBakt1992; 276:221–230
BartholomeuszRC,
ForrestRD,
LabrooyJT,
EyPL,
PyleD,
ShearmanDJ,
RowleyD.
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal response. Immunology1990; 69:190–194
QuidingM,
NordstromI,
KilanderA et al. Intestinal immune response in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-)’ production and evokes local immunological memory. Clin Invest1991; 88:143–148